Related Experiment Video
Updated: May 21, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Autocrine/paracrine TGF-β1 inhibits Langerhans cell migration
Aleh Bobr1, Botond Z Igyarto, Krystal M Haley
1Department of Dermatology, Center for Immunology, University of Minnesota, Minneapolis, MN 55455, USA.
Insights
Transforming growth factor-beta 1 (TGF-β1) directly inhibits Langerhans cell (LC) migration. This discovery in skin-resident dendritic cells (DCs) reveals a new therapeutic target for inflammatory skin diseases.
Area of Science:
- Immunology
- Dermatology
- Cell Biology
Background:
- Langerhans cells (LCs) are epidermal dendritic cells (DCs) crucial for skin immunity.
- Transforming growth factor-beta 1 (TGF-β1) is highly expressed by LCs and regulates immune responses.
- Investigating the role of LC-derived TGF-β1 is challenging due to its essential role in LC development.
Purpose of the Study:
- To develop a model for inducible, LC-specific gene deletion to study TGF-β1 function.
- To elucidate the role of TGF-β1 in regulating LC migration in the skin.
Main Methods:
- Engineered transgenic huLangerin-CreER(T2) mice for inducible LC-specific gene excision.
- Generated huLangerin-CreER(T2) × TGF-βRII(fl) and huLangerin-CreER(T2) × TGF-β1(fl) mouse models.
- Analyzed LC migration, costimulatory marker expression, and cytokine levels post-gene deletion.
Main Results:
- Inducible deletion of TGF-β receptor II (TGFβRII) or TGF-β1 in LCs triggered significant LC migration to lymph nodes.
- LC migration occurred without altering costimulatory molecule expression or inflammatory cytokine profiles.
- Decreased p-SMAD2/3 levels in LCs indicated reduced TGF-β signaling prior to inflammation.
Conclusions:
- TGF-β1 acts in an autocrine/paracrine manner to inhibit both steady-state and inflammation-induced LC migration.
- Targeting the TGF-β1 pathway in LCs presents a potential therapeutic strategy for skin diseases.
Abstract:
Langerhans cells (LCs) are skin-resident dendritic cells (DC) located in the epidermis that migrate to skin-draining lymph nodes during the steady state and in response to inflammatory stimuli. TGF-β1 is a critical immune regulator that is highly expressed by LCs. The ability to test the functional importance of LC-derived TGF-β1 is complicated by the requirement of TGF-β1 for LC development and by the absence of LCs in mice with an LC-specific ablation of TGF-β1 or its receptor. To overcome these problems, we have engineered transgenic huLangerin-CreER(T2) mice that allow for inducible LC-specific excision. Highly efficient and LC-specific expression was confirmed in mice bred onto a YFP Cre reporter strain. We next generated huLangerin-CreER(T2) × TGF-βRII(fl) and huLangerin-CreER(T2) × TGF-β1(fl) mice. Excision of the TGFβRII or TGFβ1 genes induced mass migration of LCs to the regional lymph node. Expression of costimulatory markers and inflammatory cytokines was unaffected, consistent with homeostatic migration. In addition, levels of p-SMAD2/3 were decreased in LCs from wild-type mice before inflammation-induced migration. We conclude that TGF-β1 acts directly on LCs in an autocrine/paracrine manner to inhibit steady-state and inflammation-induced migration. This is a readily targetable pathway with potential therapeutic implications for skin disease.
Related Concept Videos
TGF - β Signaling Pathway
Cell Migration
Cell Migration
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Intracellular Signaling Affects Focal Adhesions
Some...
Regulation of Angiogenesis and Blood Supply
